In this week’s HealthCap Weekly Wrap, we examine major CMS policy and rating updates, ongoing legal challenges to audit practices that affect Five-Star ratings, and an innovative example of how technology can enhance resident engagement when paired with strong staff involvement. From regulatory changes to practical resident care strategies, these stories highlight issues that senior care professionals should be watching closely.

To listen to this information as a podcast, please click below.

In this episode of HealthCap Weekly Wrap, we explore five stories shaping the senior care industry, from national vaccine policy and healthcare regulation to quality reporting audits and emerging clinical research. We discuss what these developments mean for senior care leaders, caregivers, and clinicians, along with practical insights that can help communities stay informed and prepared.

Welcome! Everything is fine…except there is still no ACIP quorum: The State of US Vaccine Policy | CIDRAP — This article examines how the continued lack of a quorum within ACIP is creating uncertainty around U.S. vaccine recommendations and broader immunization policy decisions.

Providers urge federal appeals court to limit major CMS fines imposed without trials — Providers are challenging the process used to impose significant CMS penalties, raising questions about due process and regulatory enforcement in healthcare.

Skin assessments, discharge function scoring lead QRP audit concerns | McKnight’s Long-Term Care News — Findings from the SNF Validation Program show that supporting documentation for skin assessments and Section GG functional scoring continues to be a common focus area during QRP audits.

Experts Establish “Gold Standard” for Measuring Delirium Severity in Patients With Dementia | Hinda and Arthur Marcus Institute for Aging Research — Researchers have developed a standardized method for measuring delirium severity in people with dementia, helping address the challenge of overlapping symptoms between the two conditions.

Apixaban Linked to Fewer Blood Clot Complications in Older Adults Than Other Blood Thinners | Hinda and Arthur Marcus Institute for Aging Research — A study of older adults treated for venous thromboembolism found that apixaban was associated with fewer blood clot complications than warfarin, while rivaroxaban showed no clear advantage over warfarin.